This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Critical Role for SLAM/SAP Signaling in the Thymic Developmental Programming of IL-17- and IFN-γ-Producing γδ T Cells.
Journal of immunology (Baltimore, Md. : 1950) · 2020
SLAMF6​ deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint.
eLife · 2020
Latest funding
- $956,250
SLAMF7 in innate immune cells and anti-cancer immunotherapy
CIHR · 2022 · Nominated PI
- $956,250
Targeting inhibitory immune checkpoints in macrophages for anti-cancer therapy
CIHR · 2021 · Nominated PI
- $908,438
The SLAM family of receptors in T cell-dependent immunity in health and diseases
CIHR · 2021 · Nominated PI
2 publications.
Critical Role for SLAM/SAP Signaling in the Thymic Developmental Programming of IL-17- and IFN-γ-Producing γδ T Cells.
Dienz O, DeVault VL, Musial SC, Mistri SK, Mei L, Baraev A, Dragon JA, Krementsov D, Veillette A, Boyson JE
SLAMF6​ deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint.
Hajaj E, Eisenberg G, Klein S, Frankenburg S, Merims S, Ben David I, Eisenhaure T, Henrickson SE, Villani AC, Hacohen N, Abudi N, Abramovich R, Cohen JE, Peretz T, Veillette A, Lotem M
SLAMF7 in innate immune cells and anti-cancer immunotherapy
Principal investigators: Veillette, André
Keywords: Anti-Tumor Immunity; Cell Signaling; Immune Checkpoints; Immunotherapy; Macrophages; Nk Cells
Targeting inhibitory immune checkpoints in macrophages for anti-cancer therapy
Principal investigators: Veillette, André
Keywords: Anti-Tumor Immunity; Cell Signaling; Immune Checkpoints; Immunotherapy; Macrophages
The SLAM family of receptors in T cell-dependent immunity in health and diseases
Principal investigators: Veillette, André
Keywords: Anti-Tumor Immunity; Cell Signaling; Immunology; Immunotherapy; Mouse Models
SLAMF6 and 2B4: roles and modes of action in normal immunity and cancer immunotherapy
Principal investigators: Veillette, André; LOTEM, MICHAL
Keywords: Cancer; Immune Cell Receptors; Melanoma; Mouse Models; Nk Cells; Signaling; T Cells
CRC Tier 1
Principal investigators: Veillette, André
Keywords: Crc
Genetic and molecular studies of lymphocyte activation, immunodeficiencies and autoimmunity
Principal investigators: Veillette, André
Keywords: Autoimmunity; Immune System; Immunology; Kinases; Phosphatases; Primary Immunodeficiencies; Receptors
10th Conference on Signalling in Normal and Cancer Cells
Principal investigators: Veillette, André
Keywords: Cancer; Signalling Pathways
PTPN12: a key regulator of receptor-mediated signals and functions in immune cells and cancer cells
Principal investigators: Veillette, André
Keywords: Immune Cells; Phagocytosis; Phosphatase; Receptors; Signaling; Tumor Cells
Harnessing the SLAM-SAP pathways to improve immune surveillance against cancer
Principal investigators: Veillette, André; Dong, Zhongjun
Keywords: Anti-Tumor Immunity; Immunology; Nk Cells; Signaling
Receptors controlling natural killer cell functions in anti-tumor immunity
Principal investigators: Veillette, André
Keywords: Cancer; Immune System; Receptors; Signaling; Tyrosine Phosphorylation
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.